NYSE · Healthcare · Drug Manufacturers - General
Latest call day: 2026-10-23 · full consensus board · graded history
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Today's calls AI
| Pharma & Managed Care · Quality | UP 83% | Quality — operating margin plus revenue growth. PFE ranks #3 of 13 in Pharma & Managed Care (83% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Bollinger Reversion | DOWN 75% | Bollinger Reversion — fade moves outside the bands. PFE ranks #8 of 13 in Pharma & Managed Care (75% bearish percentile), so the agent calls it DOWN for the next session. |
| Pharma & Managed Care · Donchian | UP 75% | Donchian — position within the Donchian channel. PFE ranks #4 of 13 in Pharma & Managed Care (75% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · RSI Mean-Reversion | DOWN 75% | RSI Mean-Reversion — oversold up / overbought down. PFE ranks #8 of 13 in Pharma & Managed Care (75% bearish percentile, RSI 78), so the agent calls it DOWN for the next session. |
| Pharma & Managed Care · Long-Term Reversal | UP 33% | Long-Term Reversal — year-long losers rebound. PFE ranks #9 of 13 in Pharma & Managed Care (33% bullish percentile, signal -31.0%), so the agent calls it UP for the next session. |
Best agents on PFE (graded record)
| Pharma & Managed Care · Low Volatility | 63% | 26/41 correct | UP |
| Pharma & Managed Care · Mean-Reversion | 56% | 24/43 correct | DOWN |
| SOTA Ensemble Agent | 56% | 5/9 correct | DOWN |
| Pharma & Managed Care · Quality | 55% | 46/84 correct | UP |
| Pharma & Managed Care · Momentum | 54% | 31/57 correct | UP |
| Pharma & Managed Care · Long-Term Reversal | 54% | 41/76 correct | UP |
| Pharma & Managed Care · Breakout | 54% | 28/52 correct | UP |
| Pharma & Managed Care · RSI Mean-Reversion | 53% | 28/53 correct | DOWN |
| Pharma & Managed Care · Regime Switch | 52% | 29/56 correct | DOWN |
| Pharma & Managed Care · MACD | 50% | 28/56 correct | UP |
Recent news
| 2026-10-24 | Pfizer reports phase 2 data for 25-valent pneumococcal vaccine · investing_com |
| 2026-10-24 | Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026 · yf_tkr_PFE |
| 2026-10-24 | The paranoid Fauci mind $MRNA $PFE $BNTX https://www.zerohedge.com/covid-19/anthony-faucis-darkest-hours · stocktwits |
| 2026-10-24 | Pfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might Seem · motley_fool |
| 2026-10-24 | Is Pfizer (PFE) Cheap As Its Enodia Deal Fuels Oncology Growth Hopes? · yf_tkr_PFE |
| 2026-10-23 | $PFE gemc · stocktwits |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。